Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters)

Recruiting now · Not applicable

Conditions studied: Breast Cancer

In brief

The purpose of this study is to test an evidence-based intervention designed to increase adherence to systemic therapy in Black women compared to enhanced usual care.

Key facts

Study ID

NCT05334732

Run by

Virginia Commonwealth University

People needed

250

Starts

2021-03-01

Expected to finish

2027-02-28

Last updated by the study team

2026-04-08

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Self-identify as Black
• Newly diagnosed (\~4 weeks post-definitive surgery and prior to initiation of adjuvant chemotherapy or endocrine therapy) patients (stage I-III)
• Eligible for chemotherapy or endocrine therapy according to NCCN guidelines, but have not initiated systemic therapy
• Ability to read and speak English
• Ability to provide meaningful consent as determined by trained study personnel and/or a member of the patient's care team
• No prior cancer treatment (other than skin cancer) in the two years preceding enrollment
• Physicians Must be a license doctor of study patient(s)
• Ability to speak English

Where it is running

• Medstar Georgetown University Hospital — Washington D.C., District of Columbia, United States (enrolling)
• MedStar Washington Hospital Center — Washington D.C., District of Columbia, United States (enrolling)
• Massey Cancer Center — Richmond, Virginia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.